menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Panacea Biotec and Sanofi reached settlement agreement for Shan6

    INDIANPHARMAPOST

    DFC Commits $20M Loan To Panacea Biotec For Hexavalent Vaccine Expansion

    INDIANPHARMAPOST

    ICMR, Panacea Biotec begin Phase 3 clinical trial of indigenous dengue vaccine

    ECONOMICTIMES

    Panacea Biotec launches EasyFourPol in India

    INDIAN PHARMA POST

    FDA Issues Form 483 to Panacea Biotec Pharma Ltd.

    FDA

    Panacea Biotech slumps 5% after US FDA issues 9 observations on Baddi facility

    MONEY CONTROL

    Two companies are conducting trials to develop a dengue vaccine, says DG ICM

    HEALTH ET

    Panacea Biotec posts Q3 FY2023 net profit at Rs.19.37 crores

    ECONOMIC TIMES

    Panacea wins contract worth $127 million from WHO, PAHO

    ECONOMIC TIMES

    U.S. FDA asks Panacea Biotec to take corrective measures at Himachal unit

    THEHINDU

    US FDA asks Panacea Biotec to take corrective measures at Himachal unit

    EXPRESS PHARMA

    Panacea Life Signs Exclusive Manufacturing Agreement with Good Pharmaceutical

    ACCESSWIRE

    Panacea Biotec sells its pharmaceutical formulation brands in India and Nepal

    BUSINESS-STANDARD

    CEPI, THSTI and Panacea to develop vaccines for betacoronaviruses

    PHARMACEUTICAL-TECHNOLOGY

    Panacea Biotec sells domestic formulation assets to Mankind Pharma for Rs 1,908 crore

    ECONOMIC TIMES

    Panacea arm defaults; lenders may extend repayment date

    ECONOMICTIMES

    Panacea Biotec supplies maiden shipment of Sputnik V’s second component

    EXPRESSPHARMA

    Panacea Biotec signs pact to manufacture 25 million doses of Sputnik V vaccine

    PHARMABIZ

    India`s Panacea Biotec to make up to 25 million doses of Sputnik V vaccine

    REUTERS

    Panacea Biotec surges 9% on DCGI`s nod to produce Sputnik V vaccine

    BUSINESS-STANDARD

    Panacea Biotec gets license to manufacture Sputnik V vaccine at Baddi

    EXPRESS PHARMA

    22nd Century Announces Restructuring of Panacea Investment

    GLOBENEWSWIRE

    RDIF, Panacea Biotec launch production of Sputnik V vaccine in India

    INDIANEXPRESS

    Sputnik V production starts in India; 100 million doses to be produced annually

    ECONOMICTIMES

    Panacea Biotec files suit against Sanofi for patent infringement

    LIVEMINT

    Panacea Biotec files suit against Sanofi for patent infringement

    ECONOMIC TIMES

    MSD Partners, Panacea`s biotech SPAC raises $200M IPO

    FIERCEBIOTECH

    India`s Panacea Biotec to produce 100 million Sputnik V doses annually: RDIF

    REUTER

    Panacea Biotech on Health Canada Inspection List

    HEALTH CANADA

    Ex-Medivation team nets $500M to take their new cancer drugmaker to Wall Street

    BIOPHARMADIVE

    USFDA cites CGMP violations at Panacea Biotec`s Baddi plant in warning letter

    TRIBUNE INDIA

    Where are the bugs? FDA knocks Indian manufacturer for `crude` microbe testing

    FIERCEPHARMA

    Panacea Biotec Limited Receives FDA Warning Letter

    FDA

    Panacea Biotec completes Phase I/II study of DengiAll vaccine

    TRIBUNE INDIA

    Panacea Biotech corrects after terminating MoU for COVID-19 vaccine

    EXPRESSPHARMA

    Panacea Biotec terminates MoU to develop, manufacture & supply

    PHARMABIZ

    Coronavirus | Seven Indian pharma players in race to develop COVID-19 vaccine

    THEHINDU

    Panacea Biotec aims to make 1 bln doses of COVID-19 vaccine candidate in 2022

    REUTERS

    Panacea Biotec signs pact to make 100 mn Sputnik V doses

    LIVEMINT

    Panacea Biotec receives $24.32 M award from U.N. Agencies

    BIOSPECTRUM ASIA

    Panacea Biotec receives USD 24.32 Million Award of Pentavalent Vaccine

    EQUITYBULLS

    Panacea Biotec bags orders worth USD 24 mn from UN agencie

    ECONOMIC TIMES

    Panacea Biotec launches diabetes drug in India

    BIOSPECTRUMASIA

    Panacea Biotec appoints Susheel Umesh

    ECONOMIC TIMES

    CR UK kicks off entrepreneurship initiative

    PHARMATIMES

    Advent International emerges sole bidder for Bharat Serums

    ECONOMIC TIMES

    Panacea Biotec gains 9% on USFDA approval for Azacitidine Injection

    MONEYCONTROL

    Panacea Biotec jumps 17% on Rs 992 crore fund infusion by Bain-Piramal fund

    BUSINESS-STANDARD

    Roivant brings Pfizer vets Azoulay, Gulfo into its C-suite

    ENDPTS

    Historic Deal Signed Between Panacea Biotec and Serum Institute of India

    PR NEWSWIRE

    Panacea Biotec surges 10% on collaboration with Serum Institute of India

    BUSINESS-STANDARD

    Panacea Biotec rallies as 22 products gets GMP compliance in Ukraine

    BUSINESS-STANDARD

    Panacea?Biotec, MSF?India oppose Pfizer’s pneumonia vaccine patent

    LIVEMINT

    Panacea promoters may demerge real estate business into separate company

    FINANCIAL EXPRESS

    Dangerous pneumonia on the loose, but affordable vaccine to get tough to procure

    FINACIAL EXPRESS

    Panacea enters collaboration with Bionpharma for generics worth $800 million

    ECONOMIC TIMES

    Narayana Hrudayalaya to buy NewRise Healthcare

    ECONOMIC TIMES

    Panacea Biotec says newly developed vaccine works better than its peers

    ECONOMIC TIMES

    Panacea biotec up 13 pact on US FDA nod for migraine drug

    ANINEWS

    Panacea Biotec Gains on Launch of Tetravalent Vaccine Easyfour-TT

    BUSINESS STANDARD

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.